Cargando…
HJURP regulates cell proliferation and chemo-resistance via YAP1/NDRG1 transcriptional axis in triple-negative breast cancer
Triple-negative breast cancer is still a difficult point in clinical treatment at present, and a deep study of its pathogenesis has great clinical value. Therefore, our research mainly focuses on exploring the progression of triple-negative breast cancer and determines the important role of the HJUR...
Autores principales: | Mao, Misha, Jia, Yunlu, Chen, Yongxia, Yang, Jingjing, Xu, Ling, Zhang, Xun, Zhou, Jichun, Li, Zhaoqing, Chen, Cong, Ju, Siwei, Wang, Linbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033877/ https://www.ncbi.nlm.nih.gov/pubmed/35459269 http://dx.doi.org/10.1038/s41419-022-04833-6 |
Ejemplares similares
-
Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer
por: Mao, Misha, et al.
Publicado: (2022) -
Multifaced roles of PLAC8 in cancer
por: Mao, Misha, et al.
Publicado: (2021) -
Polyphyllin Ⅲ-Induced Ferroptosis in MDA-MB-231 Triple-Negative Breast Cancer Cells can Be Protected Against by KLF4-Mediated Upregulation of xCT
por: Zhou, Yulu, et al.
Publicado: (2021) -
PLCA8 suppresses breast cancer apoptosis by activating the PI3k/AKT/NF‐κB pathway
por: Mao, Misha, et al.
Publicado: (2019) -
STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1
por: Li, Zhaoqing, et al.
Publicado: (2021)